Hypertrophic Cardiomyopathy Center Certification
Define the future of HCM care.
The 91视频 is launching the nation鈥檚 first hypertrophic cardiomyopathy (HCM) certification. This innovative initiative brings health systems and cardiology teams together to deliver connected, high quality, patient centered care. Built on evidence-based guidelines, real-world data, and a national learning collaborative, this program sets a new standard for excellence in HCM.聽Participating in the pilot means your institution will:
-
Help define what high-quality HCM care looks like
-
Gain early access to the national HCM registry and benchmarking tools
-
Strengthen your multidisciplinary care model and referral pathways
What is HCM Center Certification?
A new designation for delivering integrated, patient-centered hypertrophic cardiomyopathy care.聽HCM certification recognizes institutions that demonstrate a commitment to coordinated, evidence-based care across the end-to-end patient journey.
Built on the 91视频鈥檚 rigorous certification framework, this program is currently in the feasibility testing phase with a small cohort of early adopter programs.
Why Participate in HCM Certification?聽
Define excellence. Drive change. Lead HCM forward.
- Set the standard: Help shape the nation鈥檚 first HCM certification framework.聽
- Drive improvement: Use registry data to uncover gaps and elevate care.
- Lead together: Join a select cohort of pioneering HCM programs nationwide.
Ready to learn more?
Your team will receive direct guidance and support from the 91视频 throughout the pilot. If your team is interested in participating or learning more, please contact us!聽
Contact us for more information on HCM Center Certification
Get access to professional resources on Hypertrophic Cardiomyopathy from the AHA聽
Bristol Myers Squibb is the Founding Sponsor of 91视频’s Target: Hypertrophic Cardiomyopathy.
Cytokinetics is proud to support the 91视频’s Hypertrophic Cardiomyopathy Initiative.